|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Institute of Environmental Health Sciences (NIEHS) |
| Information provided by: | National Institute of Environmental Health Sciences (NIEHS) |
| ClinicalTrials.gov Identifier: | NCT00011726 |
Purpose
We are examining the role of maternal bone lead turnover during pregnancy and lactation as a potential source of lead exposure for the fetus and the infant (via breast milk). A cohort, ascertained at entry to care, consists of >1000 women to be followed through pregnancy. In the postpartum subjects are recruited for a nested case control study to assess the influence of lactation on maternal bone density, maternal blood lead and breast milk lead.
| Condition |
|
Lead Poisoning |
| MedlinePlus related topics: | Breast Feeding Lead Poisoning Poisoning |
| Study Type: | Observational |
| Study Design: | Natural History, Longitudinal, Convenience Sample, Prospective Study |
Eligibility
| Ages Eligible for Study: | 12 Years to 35 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Contacts and Locations
More Information
| Study ID Numbers: | 7437-CP-001 |
| First Received: | February 27, 2001 |
| Last Updated: | March 22, 2006 |
| ClinicalTrials.gov Identifier: | NCT00011726 |
| Health Authority: | United States: Federal Government |
|
|